PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New molecular targets identified in some hard-to-treat melanomas provide potential treatment option

2013-12-31
(Press-News.org) Contact information: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
Rubenstein Associates, Inc.
New molecular targets identified in some hard-to-treat melanomas provide potential treatment option

December 30, 2013 New York, NY / Los Angeles, CA: Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

According to Dr. Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center in Nashville, Tenn., "About 35 percent of melanomas are, as of today, considered 'pan-negative,' which means they are devoid of any previously known driver mutations in the genes BRAF, NRAS, KIT, GNAQ, and GNA11." Dr. Sosman explained that at Vanderbilt, researchers have been interested in looking at patients whose tumors have none of these driver mutations, to see what their tumors do have that can be targeted therapeutically. In some cancers, two or more genes fuse erroneously to produce abnormal proteins, which can function as the "drivers" of those cancers. –

"Performing a sophisticated analysis called targeted next-generation sequencing, it appears that about 8 percent of pan-negative melanomas have BRAF fusions," said Sosman. "Our results are important because they obviously suggest that there probably are other, as yet unidentified, molecular changes that make these melanomas susceptible to drugs that are available right now."

"It is very exciting to see work of Stand Up To Cancer funded researchers yield important results which advance our understanding of cancers and accelerate the science towards treatments that can make a difference for patients," stated Sherry Lansing, co-founder & member of the SU2C Council of Founders and Advisors. This research is a direct outcome from the Stand Up To Cancer Melanoma Dream Team Grant and involved the work of a Stand Up To Cancer Innovative Research Grant recipient, representing work made possible by both funding models created by SU2C to focus on groundbreaking translational research aimed at getting new therapies to patients quickly. To date, SU2C has funded $139.5 million for 11 Dream Teams and $19.4 million for 26 IRG research grants for brightest young researchers across disciplines to think out of the box and attempt to make major breakthroughs in their field with bold research projects.

In a pan-negative melanoma sample from one of their patients, Drs. Sosman and Pao and their colleagues identified a fusion between two genes, PAPSS1 and BRAF, which they called PAPSS1-BRAF. They then evaluated melanomas from an additional 51 patients, 24 of which were pan-negative. In one of these 24 pan-negative samples, they identified a second novel BRAF fusion, called TRIM24-BRAF.

The investigators conducted further studies in the laboratory and found that both BRAF fusions activated a pathway in the cancer cells called the MAPK signaling pathway. They then treated these fusion-bearing cells either with the BRAF inhibitor vemurafenib or with trametinib, a drug that inhibits a protein in the MAPK signaling pathway called MEK. They found that signaling induced by the BRAF fusions was not responsive to vemurafenib but could be inhibited by trametinib, which led them to suggest that the novel fusions they identified could make melanoma cells harboring them sensitive to MEK inhibitors.

"One of the primary objectives of Stand Up To Cancer is to accelerate the development of effective treatments to help patients. This research from Drs. Sosman and Pao advances that objective because identifying novel genetic mutations helps identify targets that might be sensitive to existing or future drug therapies," explained William G. Nelson, M.D., Ph.D., a member of the SU2C Scientific Advisory Committee and director of the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University in Baltimore, MD.



INFORMATION:



In addition to funding from the Stand Up To Cancer Melanoma Dream Team Grant and a Stand Up to Cancer Innovative Research Grant, this research was supported by the James C. Bradford Family Foundation, the American Cancer Society, the National Cancer Institute and the Joanna M. Nicolay Melanoma Foundation 2013 Research Scholar Award. Sosman is on the advisory board for GlaxoSmithKline PLC.

For more information on Stand Up To Cancer visit http://www.standup2cancer.org.

About Stand Up To Cancer

Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about progress being made in the fight against the disease. As SU2C's scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, Ph.D., conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.

Current members of the SU2C Council of Founders and Advisors (CFA) include Talk Show Host, Journalist and well-known Cancer Advocate Katie Couric; Sherry Lansing, Chairperson of the Entertainment Industry Foundation's Board of Directors and Founder of the Sherry Lansing Foundation; EIF President and CEO Lisa Paulsen; EIF Senior Vice President Kathleen Lobb; Rusty Robertson and Sue Schwartz of the Robertson Schwartz Agency; Pamela Oas Williams, President of Laura Ziskin Productions and Executive Producer of Stand Up To Cancer's In-house Production Team, and Nonprofit Executive Ellen Ziffren. All current members of the CFA were co-producers of the 2012 televised special. The late co-founder Laura Ziskin executive produced both the Sept. 5, 2008, and Sept. 10, 2010, broadcasts. SU2C was formally launched on May 27, 2008. Sung Poblete, Ph.D., R.N., has served as SU2C's president and CEO since 2011.



ELSE PRESS RELEASES FROM THIS DATE:

Sleep to protect your brain

2013-12-31
Sleep to protect your brain A new study from Uppsala University, Sweden, shows that one night of sleep deprivation increases morning blood concentrations of NSE and S-100B in healthy young men. These molecules are typically found in the brain. Thus, ...

Researchers use Hubble Telescope to reveal cloudy weather on alien world

2013-12-31
Researchers use Hubble Telescope to reveal cloudy weather on alien world Weather forecasters on exoplanet GJ 1214b would have an easy job. Today's forecast: cloudy. Tomorrow: overcast. Extended outlook: more clouds. A team of scientists led by researchers in ...

Hyperhomocysteinemia patients with dyslipidemia are more likely to have stroke

2013-12-31
Hyperhomocysteinemia patients with dyslipidemia are more likely to have stroke Hyperhomocysteinemia and abnormal blood lipids are independent risk factors for stroke. However, whether both factors exert a synergistic effect in the onset of stroke remains unclear. ...

Fetal umbilical vein for reconstruction of middle cerebral artery

2013-12-31
Fetal umbilical vein for reconstruction of middle cerebral artery Umbilical vein has been substituted for artery in vascular transplantation, but it remains unclear whether the stress relaxation and creep between these vessels are consistent. A recent study reported ...

PLGA tubes are superior to autologous nerve graft for repaired sciatic nerve

2013-12-31
PLGA tubes are superior to autologous nerve graft for repaired sciatic nerve The viscoelasticity of natural and artificial biomaterials can be suitable for human physiological function by matching stress relaxation and creep properties. Dr. Chengdong Piao and ...

Large-aperture planar lens antennas with gradient refractive index

2013-12-31
Large-aperture planar lens antennas with gradient refractive index It was recently shown that large-aperture lens antennas can be designed by using gradient-index (GRIN) metamaterials and that higher directivity and gain can be obtained than with traditional dielectric lens antennas. ...

Cloud mystery solved: Global temperatures to rise at least 4°C by 2100

2013-12-31
Cloud mystery solved: Global temperatures to rise at least 4°C by 2100 Cloud impact on climate sensitivity unveiled

Finnish research team reveals how emotions are mapped in the body

2013-12-31
Finnish research team reveals how emotions are mapped in the body Researchers Aalto University have revealed how emotions are experienced in the body Researchers Aalto University have revealed how emotions are experienced in the body. Emotions adjust our ...

Competition in a rough neighborhood: Plant success in a desert environment

2013-12-31
Competition in a rough neighborhood: Plant success in a desert environment Water use efficiency and relative growth rate govern competitive interactions in desert winter annuals Many people think of deserts as inhospitable places devoid of life, but numerous plants ...

Loyola bioethics study finds medical students concerned about desensitization to dying patients

2013-12-31
Loyola bioethics study finds medical students concerned about desensitization to dying patients Loyola's Neiswanger Institute study finds medical students concerned about becoming insensitive when dealing with a dying patient MAYWOOD, Ill. – The imminent death ...

LAST 30 PRESS RELEASES:

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

[Press-News.org] New molecular targets identified in some hard-to-treat melanomas provide potential treatment option